- Search results for 1938056-90-6
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "1938056-90-6"!
Close filters
Filter by:
No results were found for the filter!
Item number: Cay42337-1
An inhibitor of the SET-PP2A protein-protein interaction, increases PP2A activity in isolated human B-CLL cells at 3 and 8 µM, does not decrease plasma membrane S1P1 levels in isolated human B-CLL cells at 8 µM, induces apoptosis in isolated human B-CLL cells when used alone or in combination with dasatinib....
| Keywords: | N-(2,2-diethoxyethyl)-4-(hexyloxy)-benzenemethanamine |
| Application: | SET (I2PP2A)-PP2A protein-protein interaction inhibitor |
| CAS | 1938056-90-6 |
| MW: | 323.47 D |
From 73.00€
*
Item number: TGM-T9744-100mg
Description: MP07-66 is a novel FTY720-analog devoid of immunosuppressive effects leads to the reactivation of PP2A, which in turn triggers apoptosis of CLL cells. Target: Phosphatase. Smiles: CCCCCCOc1ccc(CNCC(OCC)OCC)cc1. References: Zonta F, et al. Lyn sustains oncogenic signaling in chronic lymphocytic leukemia...
| CAS | 1938056-90-6 |
| MW: | 323.47 D |
From 37.00€
*
